Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA
Seeta Poudel
Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA
Kenneth D. Smith
L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA
Adriana Estrada
Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA
Rajkumar Lakshmanaswamy
Center of Emphasis in Cancer, Department of Molecular and Translation Medicine, Paul L. Foster School of Medicine, Texas Tech Health Science Center El Paso, El Paso, TX 79905, USA
Breast cancer is the most commonly diagnosed cancer in women worldwide. Major advances have been made towards breast cancer prevention and treatment. Unfortunately, the incidence of breast cancer is still increasing globally. Metabolomics is the field of science which studies all the metabolites in a cell, tissue, system, or organism. Metabolomics can provide information on dynamic changes occurring during cancer development and progression. The metabolites identified using cutting-edge metabolomics techniques will result in the identification of biomarkers for the early detection, diagnosis, and treatment of cancers. This review briefly introduces the metabolic changes in cancer with particular focus on breast cancer.
